Moreover, upregulation of MHC class II (MHC II) on microglia in PD SN may also activate CD4+ T cells that can drive PD-specific antibody responses or inflict deleterious effects through the Fas ligand pathway [19,22,63]. This evidence concerns the gene CD4 and Parkinson disease.